Supply Chain

Gadolinium Supply Chain: From Mine to Market

Gadolinium follows the standard rare earth supply chain with China controlling ~95% of production. It is found in both light REE ores (bastnasite, monazite) and heavy REE sources (ion-adsorption clays). The most commercially significant application is in MRI contrast agents, where gadolinium-based chelates are injected intravenously to enhance imaging contrast. Pharmaceutical-grade gadolinium requires extremely high purity (99.99%+) and compliance with drug manufacturing standards. The medical supply chain involves rare earth separation in China, purification to pharmaceutical grade by specialty chemical companies, and chelate formulation by medical imaging firms (Bayer, GE, Bracco, Guerbet). Gadolinium has the highest thermal neutron absorption cross-section of any stable element, making it valuable for nuclear applications.

Production Geography

Global Gadolinium production is led by China, which accounts for approximately 95% of world output, followed by Myanmar. The full list of major producing nations includes China, Myanmar, Australia. This geographic concentration means that disruptions in key producing regions can have outsized impacts on global supply and pricing.

Extraction Methods

Gadolinium is extracted using the following primary methods:

• Byproduct of bastnasite/monazite mining
• Ion-adsorption clay leaching

Processing and Intermediate Products

Gadolinium is primarily sourced from Bastnasite, Monazite, Ion-adsorption clays. After extraction, the raw material undergoes multiple processing steps including beneficiation, chemical treatment, and refining to reach the purity levels required by downstream industries. Typical ore grades range from 0.05-0.2% Gd2O3.

Key Supply Chain Participants

The Gadolinium supply chain involves these major companies:

Supply Chain Vulnerabilities

Key vulnerabilities in the Gadolinium supply chain include concentration of 95% of production in China, limited processing capacity diversification, and long lead times for new mining projects. The high supply risk rating reflects the severity of these concentration risks and the difficulty of rapidly establishing alternative supply sources.